Literature DB >> 10092318

Evolution of acute cytomegalovirus gastritis to chronic gastrointestinal dysmotility in a nonimmunocompromised adult.

T V Nowak1, M Goddard, B Batteiger, O W Cummings.   

Abstract

A 30-year-old nonimmunocompromised woman developed chronic gastrointestinal dysmotility as a consequence of acute cytomegalovirus infection. The acute nature of the infection was documented by high immunoglobulin M antibody titer to cytomegalovirus (CMV); the chronicity of the infection was shown by persistence of CMV in biopsy specimens of her gastrointestinal tract over a 21/2-year period. Gastrointestinal dysmotility was confirmed by delayed emptying on gastric nuclear scintigraphy, by retrograde propagation of migrating myoelectric complexes on small intestinal manometry, and by presence of tachygastria on cutaneous electrogastrography. The patient's nausea, vomiting, abdominal pain, and early satiety resolved after a short course of treatment with leuprolide acetate but returned after medication was discontinued. Her symptoms persisted despite clearance of CMV from the gastrointestinal tract after a course of treatment with ganciclovir. These observations show that acute CMV infection can cause gastrointestinal dysmotility in nonimmunocompromised individuals and that the disturbance in gastrointestinal motor function may persist for years after viral infection of the gastrointestinal tract has been eradicated.

Entities:  

Mesh:

Year:  1999        PMID: 10092318     DOI: 10.1016/s0016-5085(99)70079-x

Source DB:  PubMed          Journal:  Gastroenterology        ISSN: 0016-5085            Impact factor:   22.682


  3 in total

1.  Gastric Outlet Obstruction due to Cytomegalovirus Infection in an Immunocompromised Patient.

Authors:  Vasileios Panteris; Antigoni Karakosta; Emmanuel Merikas; George Peros; John K Triantafillidis
Journal:  Case Rep Gastroenterol       Date:  2009-09-12

2.  Inflammatory causes of gastroparesis: report of five cases.

Authors:  H Pande; B E Lacy; M D Crowell
Journal:  Dig Dis Sci       Date:  2002-12       Impact factor: 3.487

3.  Severe Cytomegalovirus Gastritis During Natalizumab-Mediated Immunosuppression.

Authors:  Stephen P Persaud; Adil Hassan; Anjum Hassan; Tariq Hassan
Journal:  ACG Case Rep J       Date:  2017-03-15
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.